Use this protein to stabilize sugar

More specifically, such a dose contains low calories and has the ability to reduce glucose growth in blood after a meal and then to improve your body's response to insulin in Type 2 diabetes patients.

Hirsra is one of the main proteins found in milk products and is known to increase the production of a peptide that resembles the glucose hormone (GLP-1), a hormone that causes insulin production, which in turn reduces growth in blood glucose after eating.

Although this is especially important for diabetics, its daily use as a natural dietary appendix was limited because of high calories content and the recommendation that it be taken 30-60 minutes before a meal.

The good news is that scientists have now been able to create a new formula, using a technology that allows grace protein to be available faster in the body so that it can be managed in a lower dose of (10g by 40 calories) and only 15 minutes before lunch.

Research Process and Results

Research, though small, had very positive results. He examined 26 patients with breast - controlled diabetes 2 (14 of whom were women aged 62). Some of the participants were taking metformine, a drug for diabetes.

Participants were accidentally divided into two groups, one received the new dose of the gray protein (10 g) at 40 calories), dissolved at 125mm water, while the other group took only water as placebo. Taking was done after eating pizza, an intervention designed to produce enough glucose after a meal.

Researchers also took blood samples from participants before a meal after consuming grey protein or placebo drinks and at regular intervals more than four hours after a meal.

After a week, participants had to repeat the procedure using the option they did not get the previous one for statistically safer results.

The results showed that during the two hours after the meal, glucose levels dropped by 22% in the group that consumed gray proteins compared to the group that consumed placebo. Moreover, insulin resistance was higher (61% in 1 hour and 66% in 2 hours, respectively) in the group of grey proteins. However, the answers to both the YY peptide and the insulinlike petopide dependent on glucose (GIP) were similar in both groups.

In general, researchers note that despite the limits of study, such as its small samples and its diversity, the study lays the groundwork for greater clinical trials that can be carried out in the future.